PMC:7560789 / 2876-3023
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 22-23 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T38 | 40-58 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T39 | 63-82 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T40 | 63-72 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T41 | 73-82 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T17 | 0-147 | Sentence | denotes | All patients received a 5-day course of hydroxychloroquine and lopinavir/ritonavir, either of which was stopped upon the emergence of side effects. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 52 | 4-12 | Species | denotes | patients | Tax:9606 |
| 60 | 40-58 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 61 | 63-82 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |